Pomdoctor (POM) Stock News
$POM · NASDAQ · 2 stories in 30 daysBORSA has published 2 stories on Pomdoctor (POM) in the past 30 days, 1 of them high impact. BORSA’s news read on POM is bearish at 27/100, +1 over 24 hours, based on 2 company events over the past 7 days. POM last closed at $0.77 on Oct 9, down 10.47% over five sessions and up 3.73% over the past month.
The wire on $POM
newest first · updated · direct subject stories onlyPomdoctor (NASDAQ: POM) issued a press release detailing its strategy to move from reactive treatment toward predictive healthcare by integrating AI, wearables, remote monitoring, and real-world data with its existing physician network and operations. CEO Zhenyang Shi commented on the opportunity. No financial or operational updates were provided.
neutral 50 · impact 10
